Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer Immunotherapy
Nano Letters · 02.04.2025 · 25 (13) · 5165-5173
DOI: 10.1021/acs.nanolett.4c06123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 24.02.2025. Verfasst von Wanqiong Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Shenzhen Medical Research Fund, The Guangdong Basic and Applied Basic Research Foundation, The Fundamental Research Funds for the Central Universities, Sun Yat-sen University.
Abstract (Originalsprache)
Oral cancer vaccines are convenient and safe, with the presence of gut-associated lymphoid tissue (GALT) involved intestinal Peyer's patch (PPs) containing microfold (M) cells and housing abundant underneath dendritic cells (DCs). Here, we found that the endocytic receptors glycoprotein 2 (GP2) and dectin-1 are respectively expressed on M cells and DCs with high specificity. Then, we discovered a gastrointestinal hydrolysis-resistant D-peptide DGPBP-2(1-8) targeting GP2 by phage display screening and optimization. DGPBP-2(1-8) was conjugated to β-glucan (dectin-1 ligand)-containing yeast capsules (GP2-YCs) to design a cascade-targeting oral vaccine platform, which can help the antigen to efficiently cross intestinal M cells and subsequently be endocytosed by underneath DCs, thus activating CD8+ T cells. More importantly, this oral vaccine can evoke not only cellular but also humoral and mucosal immune responses. Therefore, this cascade-targeting oral vaccine could serve as a novel platform for cancer immunotherapy and infectious disease prevention as well.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
ORCID-Profile: Youmei Xiao, Yanfeng Gao
Förderung
- Shenzhen Medical Research Fund
- The Guangdong Basic and Applied Basic Research Foundation
- The Fundamental Research Funds for the Central Universities, Sun Yat-sen University
- The Postdoctoral Fellowship Program of CPSF
- The National Natural Science Foundation of China
- The "Pearl River Talent Plan" Innovation and Entrepreneurship Team Project of Guangdong Province
Zitieren
APA
Li, W., Yang, X., Wang, M., Hu, Z., Chen, S., Sui, X., Chen, D., Niu, X., Liu, J., Xiao, Y., Zhou, X., Chen, G., & Gao, Y. (2025). Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer Immunotherapy. Nano Letters, 25(13), 5165-5173. https://doi.org/10.1021/acs.nanolett.4c06123
Vancouver
Li W, Yang X, Wang M, Hu Z, Chen S, Sui X, et al. Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer Immunotherapy. Nano Letters. 2025;25(13):5165-5173. doi:10.1021/acs.nanolett.4c06123
BibTeX
@article{Li2025,
author = {Li, Wanqiong and Yang, Xin and Wang, Mengfan and Hu, Zheng and Chen, Shaomeng and Sui, Xinghua and Chen, Danhong and Niu, Xiaoshuang and Liu, Juan and Xiao, Youmei and Zhou, Xiuman and Chen, Guanyu and Gao, Yanfeng},
title = {Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer Immunotherapy},
journal = {Nano Letters},
year = {2025},
volume = {25},
number = {13},
pages = {5165--5173},
doi = {10.1021/acs.nanolett.4c06123}
}
EUVIMED